Back
Century Therapeutics Stock Predictions

How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
30
IPSC
Century Therapeutics
Last Price:
$0.53
Seasonality Move:
-12.03%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaCentury Therapeutics Stock Forecast
-
Is Century Therapeutics Stock Undervalued?The current Century Therapeutics [IPSC] share price is $0.57. The Score for IPSC is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
IPSC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Century Therapeutics Stock Go Up Next Year?
Data Unavailable
Century Therapeutics Stock Rating
Data Unavailable
Century Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
centurytx.com
52-Week Data
52-Week High:
3.29
52-Week Low:
0.34
Prediction Charts
Market Cap:
48.9M
Price in USD:
0.57
Volume:
446.8K
Beta:
1.80
Technical Analysis
SMA50:
0.56
SMA100:
0.59
SMA200:
0.96
52-Wk Change:
-76.93%
Stock Predictions
-
Is Century Therapeutics stock public?Yes, Century Therapeutics is a publicly traded company.
-
What is the Century Therapeutics stock quote today?The Century Therapeutics stock price is 0.57 USD today.
-
How to buy Century Therapeutics stock online?You can buy Century Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-6 | 0.57 | 0.62 | 0.65 | 0.56 |
Jun-9 | 0.62 | 0.63 | 0.64 | 0.61 |
Jun-10 | 0.65 | 0.63 | 0.66 | 0.62 |
Jun-11 | 0.65 | 0.61 | 0.65 | 0.57 |
Jun-12 | 0.62 | 0.60 | 0.62 | 0.59 |
Jun-13 | 0.60 | 0.58 | 0.61 | 0.56 |
Jun-16 | 0.59 | 0.58 | 0.61 | 0.58 |
Jun-17 | 0.58 | 0.59 | 0.61 | 0.58 |
Jun-18 | 0.58 | 0.59 | 0.60 | 0.58 |
Jun-20 | 0.59 | 0.58 | 0.60 | 0.57 |
Jun-23 | 0.58 | 0.58 | 0.59 | 0.55 |
Jun-24 | 0.58 | 0.59 | 0.60 | 0.57 |
Jun-25 | 0.60 | 0.57 | 0.60 | 0.56 |
Jun-26 | 0.57 | 0.57 | 0.59 | 0.55 |
Century Therapeutics Earnings
Data Unavailable
Century Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.03 per share, an increase this year of $1.32 per share, and a decrease next year of $1.37 per share.
* Century Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.